Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 ,inter alia, to consider and approve This is to inform you that meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma Limited has informed the BSE that its Board of Directors will meet on Tuesday, March 24, 2026, at its registered office in Rajkot, Gujarat. The Board will, among other things, consider a proposal to increase the Authorized Share Capital of the company, which will require shareholder approval. It will also consider and recommend the issuance of Bonus Equity Shares, which is also subject to member approval. As per SEBI insider trading rules, the trading window for designated persons and their immediate relatives will remain closed from March 18, 2026, to March 26, 2026. The intimation has been signed by Managing Director Tejash Hathi.
If approved by shareholders, the bonus share issue would reward existing shareholders with additional shares, while the increase in authorized capital provides room for future fundraising or further bonus/issuance plans. This is typically viewed as a positive signal for retail investors, though actual benefits depend on the final bonus ratio approved at the meeting.